Pathology AI Under a Central Lab Model

September 25, 2018 – Pathology AI Under a Central Lab Model: a cost-effective alternative and smart intermediate step for risk mitigation of a distributed medical device. A pathology AI system with an intended use for clinical diagnostics (Dx), prognostics (Px) or...

Flagship Receives Global Technology Innovation Award

Frost & Sullivan News Release: Flagship Biosciences Recognized by Frost & Sullivan for Its Industry-leading AI-powered cTA® Platform for Predictive Diagnostics Santa Clara, CA, September 18, 2018 – Based on its recent analysis of the global market for...